Transcode Therapeutics Stock Price History
RNAZ Stock | USD 0.35 0.01 2.94% |
If you're considering investing in Transcode Stock, it is important to understand the factors that can impact its price. As of today, the current price of Transcode Therapeutics stands at 0.35, as last reported on the 30th of November, with the highest price reaching 0.37 and the lowest price hitting 0.33 during the day. Transcode Therapeutics is dangerous given 3 months investment horizon. Transcode Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.11, which indicates the firm had a 0.11% return per unit of risk over the last 3 months. We were able to analyze twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.31% are justified by taking the suggested risk. Use Transcode Therapeutics Coefficient Of Variation of 1324.66, risk adjusted performance of 0.0671, and Semi Deviation of 6.97 to evaluate company specific risk that cannot be diversified away.
At this time, Transcode Therapeutics' Other Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 188 K in 2024, whereas Common Stock is likely to drop 59.85 in 2024. . At this time, Transcode Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.0007 in 2024, whereas Price Earnings Ratio is likely to drop (0.07) in 2024. Transcode Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Transcode |
Sharpe Ratio = 0.1069
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | RNAZ | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
12.27 actual daily | 96 96% of assets are less volatile |
Expected Return
1.31 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Transcode Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Transcode Therapeutics by adding it to a well-diversified portfolio.
Price Book 3.5855 | Book Value 2.615 | Enterprise Value 4.2 M | Enterprise Value Ebitda (0.59) | Shares Float 17.3 M |
Transcode Therapeutics Stock Price History Chart
There are several ways to analyze Transcode Stock price data. The simplest method is using a basic Transcode candlestick price chart, which shows Transcode Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 15, 2024 | 0.74 |
Lowest Price | September 12, 2024 | 0.25 |
Transcode Therapeutics November 30, 2024 Stock Price Synopsis
Various analyses of Transcode Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Transcode Stock. It can be used to describe the percentage change in the price of Transcode Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Transcode Stock.Transcode Therapeutics Price Daily Balance Of Power | 0.25 | |
Transcode Therapeutics Accumulation Distribution | 20,621 | |
Transcode Therapeutics Price Rate Of Daily Change | 1.03 |
Transcode Therapeutics November 30, 2024 Stock Price Analysis
Transcode Stock Price History Data
The price series of Transcode Therapeutics for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 0.51 with a coefficient of variation of 33.24. The price distribution for the period has arithmetic mean of 0.45. The median price for the last 90 days is 0.45. The company completed stock split (1:40) on 16th of January 2024.Open | High | Low | Close | Volume | ||
11/29/2024 | 0.36 | 0.37 | 0.33 | 0.35 | 190,740 | |
11/27/2024 | 0.37 | 0.38 | 0.33 | 0.34 | 658,129 | |
11/26/2024 | 0.37 | 0.46 | 0.34 | 0.38 | 1,446,982 | |
11/25/2024 | 0.38 | 0.38 | 0.33 | 0.34 | 937,456 | |
11/22/2024 | 0.39 | 0.39 | 0.36 | 0.38 | 269,811 | |
11/21/2024 | 0.33 | 0.39 | 0.33 | 0.38 | 519,415 | |
11/20/2024 | 0.34 | 0.34 | 0.33 | 0.34 | 203,916 | |
11/19/2024 | 0.32 | 0.34 | 0.32 | 0.33 | 116,267 | |
11/18/2024 | 0.32 | 0.35 | 0.32 | 0.33 | 218,404 | |
11/15/2024 | 0.34 | 0.37 | 0.31 | 0.34 | 264,385 | |
11/14/2024 | 0.37 | 0.38 | 0.34 | 0.35 | 221,226 | |
11/13/2024 | 0.39 | 0.39 | 0.36 | 0.36 | 406,426 | |
11/12/2024 | 0.39 | 0.40 | 0.31 | 0.39 | 868,329 | |
11/11/2024 | 0.45 | 0.46 | 0.39 | 0.40 | 846,565 | |
11/08/2024 | 0.49 | 0.49 | 0.45 | 0.45 | 221,096 | |
11/07/2024 | 0.47 | 0.47 | 0.45 | 0.47 | 304,557 | |
11/06/2024 | 0.51 | 0.51 | 0.45 | 0.47 | 558,905 | |
11/05/2024 | 0.52 | 0.53 | 0.48 | 0.51 | 417,889 | |
11/04/2024 | 0.50 | 0.55 | 0.49 | 0.52 | 576,684 | |
11/01/2024 | 0.46 | 0.49 | 0.46 | 0.48 | 188,730 | |
10/31/2024 | 0.49 | 0.50 | 0.46 | 0.47 | 454,603 | |
10/30/2024 | 0.56 | 0.57 | 0.48 | 0.50 | 1,167,166 | |
10/29/2024 | 0.59 | 0.59 | 0.55 | 0.56 | 392,772 | |
10/28/2024 | 0.60 | 0.62 | 0.56 | 0.60 | 658,610 | |
10/25/2024 | 0.64 | 0.67 | 0.58 | 0.59 | 586,792 | |
10/24/2024 | 0.66 | 0.70 | 0.63 | 0.65 | 507,058 | |
10/23/2024 | 0.63 | 0.77 | 0.61 | 0.67 | 2,667,349 | |
10/22/2024 | 0.63 | 0.63 | 0.59 | 0.61 | 282,462 | |
10/21/2024 | 0.63 | 0.64 | 0.58 | 0.62 | 452,785 | |
10/18/2024 | 0.63 | 0.64 | 0.60 | 0.61 | 386,949 | |
10/17/2024 | 0.69 | 0.69 | 0.57 | 0.60 | 964,704 | |
10/16/2024 | 0.75 | 0.75 | 0.66 | 0.68 | 1,063,479 | |
10/15/2024 | 0.69 | 0.78 | 0.67 | 0.74 | 1,194,880 | |
10/14/2024 | 0.68 | 0.72 | 0.63 | 0.70 | 724,970 | |
10/11/2024 | 0.73 | 0.80 | 0.66 | 0.70 | 2,601,033 | |
10/10/2024 | 0.54 | 0.75 | 0.54 | 0.73 | 4,399,595 | |
10/09/2024 | 0.49 | 0.57 | 0.47 | 0.54 | 1,342,430 | |
10/08/2024 | 0.50 | 0.52 | 0.40 | 0.48 | 6,076,201 | |
10/07/2024 | 0.59 | 0.62 | 0.54 | 0.54 | 727,529 | |
10/04/2024 | 0.64 | 0.64 | 0.55 | 0.59 | 830,172 | |
10/03/2024 | 0.50 | 0.68 | 0.48 | 0.61 | 3,777,949 | |
10/02/2024 | 0.50 | 0.50 | 0.45 | 0.50 | 554,179 | |
10/01/2024 | 0.57 | 0.58 | 0.40 | 0.49 | 2,671,523 | |
09/30/2024 | 0.63 | 0.63 | 0.56 | 0.57 | 920,297 | |
09/27/2024 | 0.61 | 0.70 | 0.51 | 0.64 | 2,671,402 | |
09/26/2024 | 0.66 | 0.73 | 0.56 | 0.62 | 4,643,829 | |
09/25/2024 | 0.41 | 0.68 | 0.41 | 0.65 | 12,731,590 | |
09/24/2024 | 0.32 | 0.45 | 0.32 | 0.42 | 5,794,494 | |
09/23/2024 | 0.35 | 0.36 | 0.28 | 0.31 | 1,391,374 | |
09/20/2024 | 0.37 | 0.38 | 0.34 | 0.35 | 1,449,099 | |
09/19/2024 | 0.36 | 0.44 | 0.36 | 0.38 | 4,617,543 | |
09/18/2024 | 0.30 | 0.40 | 0.28 | 0.35 | 6,330,215 | |
09/17/2024 | 0.27 | 0.34 | 0.27 | 0.29 | 4,094,538 | |
09/16/2024 | 0.27 | 0.27 | 0.26 | 0.26 | 437,707 | |
09/13/2024 | 0.25 | 0.26 | 0.25 | 0.26 | 315,132 | |
09/12/2024 | 0.26 | 0.26 | 0.24 | 0.25 | 276,317 | |
09/11/2024 | 0.25 | 0.26 | 0.24 | 0.26 | 465,736 | |
09/10/2024 | 0.25 | 0.26 | 0.25 | 0.26 | 507,188 | |
09/09/2024 | 0.26 | 0.26 | 0.24 | 0.26 | 516,411 | |
09/06/2024 | 0.27 | 0.28 | 0.25 | 0.26 | 1,147,060 | |
09/05/2024 | 0.25 | 0.30 | 0.22 | 0.28 | 15,007,270 |
About Transcode Therapeutics Stock history
Transcode Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Transcode is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Transcode Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Transcode Therapeutics stock prices may prove useful in developing a viable investing in Transcode Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 179 K | 188 K | |
Net Loss | -15.8 M | -15 M |
Transcode Therapeutics Stock Technical Analysis
Transcode Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Transcode Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Transcode Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Transcode Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Transcode to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0671 | |||
Jensen Alpha | 1.11 | |||
Total Risk Alpha | (1.12) | |||
Sortino Ratio | 0.0978 | |||
Treynor Ratio | (0.56) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Transcode Stock Analysis
When running Transcode Therapeutics' price analysis, check to measure Transcode Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transcode Therapeutics is operating at the current time. Most of Transcode Therapeutics' value examination focuses on studying past and present price action to predict the probability of Transcode Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transcode Therapeutics' price. Additionally, you may evaluate how the addition of Transcode Therapeutics to your portfolios can decrease your overall portfolio volatility.